Brian J. Francica

发表

Paucity of PD-L1 Expression in Prostate Cancer: Innate and Adaptive Immune Resistance

M. Scott Lucia, Charles G. Drake, Allison M. Martin, 2015, Prostate Cancer and Prostatic Disease.

Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity.

Yan Feng, S. Bender, Thomas E. Hudson, 2018, Cell reports.

Stereotactic Radiation Therapy Augments Antigen-Specific PD-1–Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen

C. Drake, T. DeWeese, C. Kochel, 2014, Cancer Immunology Research.

Characterization of convergent thickening, a major convergence force producing morphogenic movement in amphibians

P. Skoglund, R. Keller, D. DeSimone, 2018, bioRxiv.

Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination

Christopher M. Jackson, J. Taube, P. Calabresi, 2015, Clinical Cancer Research.

Peptide-TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T cell immunity to tumor antigens

C. Drake, O. Lantz, L. Seymour, 2019, Nature Biotechnology.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Manish R. Patel, Charles J. Vaske, Joe Y. Chang, 2016, Journal for Immunotherapy of Cancer.

Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy

C. Drake, T. DeWeese, A. Korman, 2018, Clinical Cancer Research.

Erratum to: Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma

C. Drake, P. Tran, D. Pardoll, 2016, Journal of Immunotherapy for Cancer.

Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma

C. Drake, P. Tran, D. Pardoll, 2015, Journal of Immunotherapy for Cancer.

Does Prophylactic Nodal Irradiation Inhibit Potential Synergy Between Radiation Therapy and Immunotherapy

C. Drake, T. DeWeese, A. Marciscano, 2016 .

Combining Intra-Tumoral Treg Depletion with Androgen Deprivation Therapy (ADT): Pre-Clinical Activity in the Myc-CaP Model

C. Drake, A. Korman, M. Selby, 2017, Prostate Cancer and Prostatic Diseases.

Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors

P. Prasit, D. Panigrahy, D. Wang, 2023, Cancer research communications.

Abstract 1202: Tumor cell intrinsic STING signaling demonstrates minimal contribution to the anti-tumor response elicited by the STING agonist ADU-S100 (MIW815)

Yan Feng, C. Cho, L. Corrales, 2019, Tumor Biology.

RELEASING THE BRAKES: STRATEGIES TO REMODEL THE TUMOR ENVIRONMENT, INCREASE IMMUNE INFILTRATE, AND INDUCE TUMOR CELL DEATH

B. Francica, Brian J. Francica, Brian Francica, 2016 .